NEUVIOR and PHARMORIS remain the operating focus. The wider VARUNÉ portfolio explores biology, space systems, AI and robotics, alongside the Labs predevelopment programme operated by NEUVIOR. VARUNÉ Group is a portfolio brand, not an asserted legal parent or holding company.
Explore the direction of each business and programme, its current stage and the company record behind it. Registration is distinct from operational capability.
The pharmaceutical company through which Varun is building systems for evidence, human judgement and accountable follow-through in medicines work.
What exists now
Incorporated in Scotland on 4 August 2025; current work includes PHARMORIS development.
NEUVIOR PHARMACEUTICALS LTD
Companies House · SC857853
An operating company is not evidence of customers, deployment or clinical outcomes.
A staff-facing system intended to connect reviewable evidence, authorised decisions and accountable follow-through.
What exists now
A controlled, non-production development programme. NEUVIOR has been selected for non-dilutive support for defined R&D project work.
Not presented as deployed, clinically validated, NHS-backed or production-ready.
A proposed research direction connecting how biological systems keep time, age, repair and respond to interventions. The five pillars are peers; no one pillar defines the whole business.
What exists now
A registered company, incorporated on 30 October 2025; its current legal name took effect on 1 September 2026.
VARUNÉ BIOSYSTEMS LTD
Companies House · 16820832
Proposed research interests do not establish validated capability, products or outcomes.
Exploring how intelligence and robotics could address complex real-world problems, with human responsibility built into the direction from the start.
What exists now
A registered company, incorporated in Scotland on 4 August 2025, with an exploratory AI and robotics direction.
VARUNÉ INTELLIGENCE LTD
Companies House · SC857816
No deployed product, customer or partnership is claimed; shared leadership does not establish ownership of other portfolio outputs.
A programme spanning medicines, novel formulations, generics, skincare and personal care, fragrance and sensory research, with longer-range manufacturing and facility planning.
What exists now
A predevelopment programme operated by NEUVIOR PHARMACEUTICALS LTD (SC857853). VARUNÉ Labs is not a separate legal company or a Biosystems subsidiary.
No confirmed facility, owned laboratory, manufacturing capability or regulated activity is claimed.
The current VARUNÉ space direction: exploratory, precommercial work towards future space systems and the questions that must be answered before they can be built.
What exists now
A registered company, incorporated in Scotland on 4 August 2025; its current legal name took effect on 1 September 2026.
VARUNÉ SPACE SYSTEMS LTD
Companies House · SC857817
An exploratory direction is not a confirmed mission, payload, partnership or flight capability.